On May 21, 2024, Quest Diagnostics Incorporated announced that it held its annual general meeting of shareholders on May 16, 2024, and declared voting results. Accordingly, a shareholder proposal regarding managing climate risk through science-based targets and transition planning, submitted by John Chevedden, was not approved by the Company shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
137.8 USD | -0.49% | -3.15% | -0.02% |
11/06 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
11/06 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.02% | 1.53TCr | |
+24.67% | 8.84TCr | |
-23.73% | 7.56TCr | |
+3.24% | 2.69TCr | |
+5.31% | 1.78TCr | |
-12.06% | 1.68TCr | |
+75.93% | 1.35TCr | |
+82.63% | 1.35TCr | |
-24.56% | 1.3TCr | |
+23.23% | 1.26TCr |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Declaration of Voting Results by Quest Diagnostics Incorporated